BPMC: Blueprint Medicines Corporation Stock

by  •  • Comments Off on BPMC: Blueprint Medicines Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5,555.61
Enterprise Value ($M) 6,164.76
Book Value ($M) 130.61
Book Value / Share 2.13
Price / Book 42.54
NCAV ($M) -110.25
NCAV / Share -1.80
Price / NCAV -50.39

Profitability (mra)
Return on Invested Capital (ROIC) -0.56
Return on Assets (ROA) -0.42
Return on Equity (ROE) -1.22

Liquidity (mrq)
Quick Ratio 3.66
Current Ratio 3.76

Balance Sheet (mrq) ($M)
Current Assets 808.39
Assets 1,049.25
Liabilities 918.64
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 249.38
Operating Income -486.28
Net Income -506.98
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -436.85
Cash from Investing 274.04
Cash from Financing 119.22

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-10 13G/A Price T Rowe Associates Inc /md/ 10.20 15.00
02-09 13G/A Fmr Llc 7.15 -6.95
02-08 13G/A Wellington Management Group Llp 7.03 -14.53
01-24 13G/A BlackRock Inc. 10.80 4.94
01-10 13G/A Vanguard Group Inc 10.06 5.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-15 10-K UNITED STATES
2023-10-26 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 99,906 587,158 17.02
2024-04-25 68,780 319,793 21.51
2024-04-24 96,768 226,912 42.65
2024-04-23 201,438 274,135 73.48
2024-04-22 235,725 244,222 96.52

(click for more detail)

Similar Companies
BMEA – Biomea Fusion, Inc. BMRN – BioMarin Pharmaceutical Inc.
BOLT – Bolt Biotherapeutics, Inc. CABA – Cabaletta Bio, Inc.
CCCC – C4 Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io